Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. A10 Networks, Inc.

6.2% sales growth and 8.96% return on equity

A10 Networks, Inc. provides software and hardware solutions in the United States, Japan, other Asia Pacific and EMEA countries, and Latin America.

A10 Networks, Inc.’s sales growth this year is anticipated to be 6.4% and 7.4% for next year.

Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 223.19M for the twelve trailing months.

A10 Networks, Inc.’s sales growth for the next quarter is 6.2%. The company’s growth estimates for the present quarter and the next is 50% and 120%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.96%.

Volatility

A10 Networks, Inc.’s last day, last week, and last month’s average volatility was a positive 7.41%, a negative 0.56%, and a positive 0.83%, respectively.

A10 Networks, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 11.60%, 6.59%, and 5.26%, respectively.

A10 Networks, Inc.’s Stock Yearly Top and Bottom Value

A10 Networks, Inc.’s stock is valued at $9.54 at 22:22 EST, way under its 52-week high of $10.94 and way above its 52-week low of $3.43.

A10 Networks, Inc.’s Moving Average

A10 Networks, Inc.’s worth is above its 50-day moving average of $9.08 and way above its 200-day moving average of $7.91.

2. Masco Corporation

6.5% sales growth and 451.65% return on equity

Masco Corporation designs, manufactures, and distributes home improvement and building products in North America, Europe, and internationally.

Masco Corporation’s sales growth this year is expected to be 6.3% and 2.9% for next year.

Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 6.97B for the twelve trailing months.

Masco Corporation’s sales growth for the next quarter is 6.5%. The company’s growth estimates for the current quarter and the next is 37% and 32.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 451.65%.

Volatility

Masco Corporation’s last day, last week, and last month’s average volatility was 3.60%, 0.68%, and 0.27%, respectively.

Masco Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 3.83%, 2.52%, and 2.65%, respectively.

Masco Corporation’s Stock Yearly Top and Bottom Value

Masco Corporation’s stock is valued at $58.43 at 22:22 EST, below its 52-week high of $60.16 and way higher than its 52-week low of $27.04.

Masco Corporation’s Moving Average

Masco Corporation’s value is above its 50-day moving average of $54.72 and higher than its 200-day moving average of $55.60.

3. Citizens & Northern Corp

31.7% sales growth and 7.06% return on equity

Citizens & Northern Corporation operates as the bank holding company for Citizens & Northern Bank that provides a range of banking and mortgage services to individual and corporate customers in North Central Pennsylvania and Southern New York.

Citizens & Northern Corp’s sales growth this year is anticipated to be 23% and 7.7% for next year.

Year-on-year quarterly revenue growth grew by 38.1%, now sitting on 88.17M for the twelve trailing months.

Citizens & Northern Corp’s sales growth for the next quarter is 31.7%. The company’s growth estimates for the current quarter and the next is a negative 8.7% and negative -7.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.06%.

Volatility

Citizens & Northern Corp’s last day, last week, and last month’s average volatility was a positive 2.25%, a negative 0.56%, and a positive 0.30%, respectively.

Citizens & Northern Corp’s last day, last week, and last month’s high and low average amplitude percentage was 3.59%, 2.94%, and 2.97%, respectively.

Citizens & Northern Corp’s Stock Yearly Top and Bottom Value

Citizens & Northern Corp’s stock is valued at $20.46 at 22:22 EST, way below its 52-week high of $27.50 and way above its 52-week low of $14.92.

Citizens & Northern Corp’s Moving Average

Citizens & Northern Corp’s value is higher than its 50-day moving average of $19.99 and way higher than its 200-day moving average of $18.25.

4. West Pharmaceutical Services, Inc.

14.4% sales growth and 19.44% return on equity

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally.

West Pharmaceutical Services, Inc.’s sales growth this year is expected to be 14.9% and 11.1% for next year.

Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 2.04B for the twelve trailing months.

West Pharmaceutical Services, Inc.’s sales growth for the next quarter is 14.4%. The company’s growth estimates for the current quarter and the next is 36.6% and 18.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.44%.

Volatility

West Pharmaceutical Services, Inc.’s last day, last week, and last month’s average volatility was a negative 1.79%, a positive 0.11%, and a positive 0.37%, respectively.

West Pharmaceutical Services, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.54%, 2.11%, and 2.48%, respectively.

West Pharmaceutical Services, Inc.’s Stock Yearly Top and Bottom Value

West Pharmaceutical Services, Inc.’s stock is valued at $299.68 at 22:22 EST, under its 52-week high of $312.12 and way higher than its 52-week low of $124.53.

West Pharmaceutical Services, Inc.’s Moving Average

West Pharmaceutical Services, Inc.’s value is higher than its 50-day moving average of $283.29 and higher than its 200-day moving average of $275.72.

5. STAAR Surgical Company

25.2% sales growth and 5.34% return on equity

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye.

STAAR Surgical Company’s sales growth this year is anticipated to be 7.7% and 25.6% for next year.

Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 156.34M for the twelve trailing months.

STAAR Surgical Company’s sales growth for the next quarter is 25.2%. The company’s growth estimates for the current quarter and the next is a negative 85.7% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.34%.

Volatility

STAAR Surgical Company’s last day, last week, and last month’s average volatility was 1.90%, 0.08%, and 0.66%, respectively.

STAAR Surgical Company’s last day, last week, and last month’s high and low average amplitude percentage was 3.01%, 4.99%, and 5.31%, respectively.

STAAR Surgical Company’s Stock Yearly Top and Bottom Value

STAAR Surgical Company’s stock is valued at $91.37 at 22:22 EST, under its 52-week high of $92.27 and way above its 52-week low of $23.20.

STAAR Surgical Company’s Moving Average

STAAR Surgical Company’s worth is way higher than its 50-day moving average of $82.06 and way above its 200-day moving average of $65.93.

6. Greenland Technologies Holding Corporation

52.4% sales growth and 8.83% return on equity

Greenland Technologies Holding Corporation, through its subsidiaries, develops and manufactures transmission products for material handling machineries in the People's Republic of China.

Greenland Technologies Holding Corporation’s sales growth this year is expected to be 37.5% and 14% for next year.

Year-on-year quarterly revenue growth grew by 38.2%, now sitting on 54.87M for the twelve trailing months.

Greenland Technologies Holding Corporation’s sales growth for the next quarter is 52.4%. The company’s growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.83%.

Volatility

Greenland Technologies Holding Corporation’s last day, last week, and last month’s average volatility was a positive 19.86%, a positive 3.84%, and a negative 0.03%, respectively.

Greenland Technologies Holding Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 23.24%, 7.45%, and 7.84%, respectively.

Greenland Technologies Holding Corporation’s Stock Yearly Top and Bottom Value

Greenland Technologies Holding Corporation’s stock is valued at $8.27 at 22:22 EST, way under its 52-week high of $11.40 and way higher than its 52-week low of $1.12.

Greenland Technologies Holding Corporation’s Moving Average

Greenland Technologies Holding Corporation’s value is way above its 50-day moving average of $7.43 and way above its 200-day moving average of $4.08.

LEAVE A REPLY

Please enter your comment!
Please enter your name here